Mettl3 sustains the stabilization of the c-MYC mRNA via the m6A modification to accelerate tumorigenesis in OSCC [36] and promotes YAP translation to induce drug resistance and metastasis in NSCLC [37]. This evidence concerns the gene MYC and non-small cell lung carcinoma.